Tumor News and Research

RSS

Multi Immersion Microscope Captures Rapid 3D Dynamics in Living Cells

An international team of researchers led by UT Southwestern Medical Center has developed a versatile light-sheet microscope that captures 3D views of biological samples, from activity inside living cells to larger tissues.

6 Nov 2026

Molecular Map Matches Patient Tumors to Targeted Clinical Trial Therapies

A new molecular map of breast cancer has identified novel forms of the disease and provides a foundation for selecting personalized treatments guided by a tumor's molecular characteristics rather than standard pathology alone.

6 Nov 2026

KARAP Deficiency Enhances Macrophage IL-10 Production and Epithelial Barrier Repair

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease in which persistent mucosal inflammation damages the epithelial barrier.

5 Nov 2026

Study Identifies Enzymatic Regulation Mechanisms Involved in Tumor Survival and Resistance Pathways

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this process are known to lead to cancer growth.

4 Nov 2026

Novel Molecular Bridge Links Coagulation Cascade with Cancer Hormonal Environment

New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence immune activity.

4 Nov 2026

Nanoparticle Displayed Antibody Fragments Ease Asthma Associated Goblet Cell Hyperplasia

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

4 Nov 2026

Innate Immune Sensor cGAS Acts as Nuclear Metabolic Regulator

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol levels inside cells and influences tumor growth and treatment response.

4 Nov 2026

Mitochondrial Iron Accumulation Drives Perforin Mediated Cancer Cell Death

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell.

2 Nov 2026

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

30 Oct 2026

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

The Spanish association “Izas, la princesa guisante” and the Pediatric Cancer Center Barcelona (PCCB) at Sant Joan de Déu Hospital have reached another milestone in the fight against childhood cancer: they have helped establish an international expert tumor board dedicated to pediatric gliomatosis cerebri.

28 Oct 2026

Researchers Develop Predictive Model for Mass Spectrometry Imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of the SureSeq™ myPanel Myeloid Fusion MRD Panel, the first-to-market dedicated fusion MRD next-generation sequencing (NGS) panel for acute myeloid leukemia (AML).

27 Oct 2026

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors.

24 Oct 2026

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Evaxion A/S, a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

From Evaxion A/S 24 Oct 2026

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

By turning a patient's own immune cells into stronger cancer-fighting cells, CAR T-cell therapy has transformed how some blood cancers are treated. But it's been harder to extend this approach to solid tumors, including cancer that has spread to the bone.

21 Oct 2026

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Immune checkpoint inhibitors (ICIs) have transformed cancer care, yet only a subset of patients benefit. A major barrier is tumor microenvironment (TME) heterogeneity: "hot" tumors are enriched with cytotoxic T lymphocytes (CTLs) and respond better, while "cold" tumors lack T-cell infiltration or are shielded by immunosuppressive barriers.

20 Oct 2026

Novel Molecular Pathway Identified to Combat T-Cell Exhaustion in Cancer

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.

16 Oct 2026

Immunometabolic Reprogramming Strategy Addresses Chronic Inflammatory Conditions

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

16 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

Comprehensive Analysis of Emerging Strategies for Targeting Cyclin-Dependent Kinases in Cancer

More than 30 years after the direct connection was established between the molecular machinery controlling cell division and cancer, a new paper traces the evolution of cyclin-dependent kinase research and outlines the next generation of CDK-targeted therapies.

15 Oct 2026

Tumor News and Research

Multi Immersion Microscope Captures Rapid 3D Dynamics in Living Cells

Molecular Map Matches Patient Tumors to Targeted Clinical Trial Therapies

KARAP Deficiency Enhances Macrophage IL-10 Production and Epithelial Barrier Repair

Study Identifies Enzymatic Regulation Mechanisms Involved in Tumor Survival and Resistance Pathways

Novel Molecular Bridge Links Coagulation Cascade with Cancer Hormonal Environment

Nanoparticle Displayed Antibody Fragments Ease Asthma Associated Goblet Cell Hyperplasia

Innate Immune Sensor cGAS Acts as Nuclear Metabolic Regulator

Mitochondrial Iron Accumulation Drives Perforin Mediated Cancer Cell Death

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

Researchers Develop Predictive Model for Mass Spectrometry Imaging

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Novel Molecular Pathway Identified to Combat T-Cell Exhaustion in Cancer

Immunometabolic Reprogramming Strategy Addresses Chronic Inflammatory Conditions

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro

Comprehensive Analysis of Emerging Strategies for Targeting Cyclin-Dependent Kinases in Cancer

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics